Pharma index surged over 4 per cent in early trade on Thursday after US President Donald Trump’s administration exempted pharmaceutical products from reciprocal tariffs. Market and industry ...

Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 14,745.22 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development manufacturing and marketing of Finished Dosage Formulations (FDF) and Active ...

Natco Pharma Ltd. is a Public Limited Listed company incorporated on 19/09/1981 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Also read: Front-end manufacturing in U.S. way forward to counter tariff impact on pharma: Natco Pharma CEO Aurobindo Pharma, Dr. Reddy’s Laboratories, Sun Pharma, Lupin, Cipla, Natco Pharma ...

Natco Pharma Limited is a vertically integrated and ... where the regulatory audit resulted in zero observations (no form 483 issued).During FY 2019-20, NATCO had 8 launches in the domestic ...

Telangana: Natco Pharma has announced the superannuation of Dr Ramesh Dandala, Executive Vice President - Technology Transfer, Intellectual Property Rights & Regulatory Affairs (API) of the Company.

Cash Taxes Paid 286.30 177.50 48.20 130.00 ...

The Quarterly Results page of Natco Pharma Ltd. presents the key result items, its comparison with the sector peers and its previous 5 Quarterly Results.

Natco Pharma has announced the supperannuation of Tummala Venkata Rao, Vice President - Production of the Company. "With effect from the closure of business hours on 31st March, 2025, Mr. Tummala ...